|
ZRANB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.673000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.619200E-01 |
| Normal-vs-Stage2 |
7.693400E-01 |
| Normal-vs-Stage3 |
4.604400E-02 |
| Normal-vs-Stage4 |
5.305600E-01 |
| Stage1-vs-Stage2 |
4.275800E-01 |
| Stage1-vs-Stage3 |
2.696200E-01 |
| Stage1-vs-Stage4 |
3.409000E-01 |
| Stage2-vs-Stage3 |
2.480800E-01 |
| Stage2-vs-Stage4 |
7.005000E-01 |
| Stage3-vs-Stage4 |
2.359800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.529600E-01 |
| Normal-vs-AfricanAmerican |
6.165200E-01 |
| Normal-vs-Asian |
8.291600E-01 |
| Caucasian-vs-AfricanAmerican |
8.375400E-01 |
| Caucasian-vs-Asian |
8.624800E-01 |
| AfricanAmerican-vs-Asian |
8.819400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.825800E-01 |
| Normal-vs-Female |
7.871800E-01 |
| Male-vs-Female |
1.089180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.296600E-01 |
| Normal-vs-Extreme_Weight |
1.938160E-01 |
| Normal-vs-Obese |
4.619400E-01 |
| Normal-vs-Extreme_Obese |
4.266000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.558400E-01 |
| Normal_Weight-vs-Obese |
4.988400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.876800E-01 |
| Extreme_Weight-vs-Obese |
5.627800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.467400E-01 |
| Obese-vs-Extreme_Obese |
8.315000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.896600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.233400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.607960E-01 |
| Normal-vs-Age(81-100Yrs) |
4.510500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.840200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.919620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.716300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.150400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.123560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.602000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.664600E-01 |
| Normal-VS-Type2 PRCC |
1.443930E-02 |
| Normal-VS-KIRP CIMP |
6.573800E-01 |
| Normal-VS-Unclassified PRCC |
7.591400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.959200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.396400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.278200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.201800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.699600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.717800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.350200E-02 |
| Normal-vs-N1 |
6.339800E-01 |
| Normal-vs-N2 |
3.192200E-01 |
| N0-vs-N1 |
1.643150E-01 |
| N0-vs-N2 |
8.090400E-01 |
| N1-vs-N2 |
4.800400E-01 |
|
|
